31

Graphy Inc.

318060 · KQ · Healthcare / Medical Devices

10,140.00KRW+330.00 (+3.36%)

Price History

Full chart

Market Stats

Previous Close9,810.00
Open10,250.00
Day Range9,940.00 – 10,600.00
52-Week Range8,210.00 – 69,000.00
Volume41.41K
Market Cap179.94B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
50-Day Avg17,752.80
200-Day Avg29,957.35

About

Graphy Inc. operates in the 3D printing materials industry. It offers shape memory aligner, permanent C&B resin, denture base, flexible denture, mouth guard, gingiva mask, and surgical guide products, as well as S-100M, a dental model material for replicating the oral environment; and replacement materials for conventional dental lab wax. The company also provides materials for producing various medical models, including training simulators and patient-specific implants; non-toxic and hypoallergenic biocompatible materials; and various materials for industries. In addition, it offers hardware products, including centrifuge, curing machine, ultrasonic cleaner and warmer, 3D printer, and scanner; and Tera Harz Smart Robot, a shape memory aligner solution. The company also exports its products. The company was founded in 2017 and is based in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Un Seob Sim
  • HeadquartersAce Gasan Pohyu, Seoul, South Korea, 08501, Korea
  • Websitehttps://www.itgraphy.com

Leadership

  • Mr. Un Seob SimCEO & Chairman · b. 1971
  • Mr. Chang-baek SeoCFO & Director · b. 1975
  • Mr. Sung-hyun ParkDirector of Operations & Executive Director · b. 1980
  • Mr. Tae-yeon JoDirector of Production & Logistics and Executive Director · b. 1968
  • Mr. Hae-Jeong LeeHead of Overseas Business Division · b. 1964
  • Mr. Yoobeom WonOverseas Sales Department Head · b. 1972
  • Mr. KwonKi Lee3D Printing Department Head · b. 1973
  • Ms. SooJin KimChief Clinical Research & Development Officer · b. 1971

Financials

Income Statement

Currency: KRW2024-12-312025-12-31
Total Revenue16.12B20.53B
Growth (%)-+27.34%
Cost of Revenue8.46B8.28B
Gross Profit7.66B12.25B
Gross Margin47.51%59.66%
Operating Expense16.83B23.30B
Operating Income-9.17B-11.05B
Operating Margin-56.87%-53.83%
EBITDA-27.96B-9.91B
EBITDA Margin-173.43%-48.28%
Net Income-32.66B-11.67B
Net Income Margin-202.58%-56.84%
R&D3.97B4.67B
R&D as % of Total Revenue24.62%22.75%
Interest Expense3.80B628.40M
Interest Expense % of Total Revenue23.57%3.06%

Balance Sheet

Currency: KRW2024-12-312025-12-31
Total Assets21.99B39.70B
Total Liabilities18.13B18.64B
Total Equity3.86B21.05B
Cash3.04B796.17M
Net Debt10.38B11.96B

Cash Flow

Currency: KRW2024-12-312025-12-31
Operating Cash Flow-9.62B-15.10B
Capital Expenditure232.33M2.95B
Free Cash Flow-9.86B-18.05B
FCF to OCF102.41%119.55%

Earnings

Report DateSep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----
EPS Actual-324.23-120.48-253.57-319.03
Surprise----
Timing----

Key Statistics & Ratios

Market Cap179.94B
Enterprise Value187.93B
Trailing P/E0.00
Forward P/E0.00
Price / Sales7.65
Price / Book11.78
Revenue (TTM)23.51B
Gross Profit (TTM)16.05B
EBITDA-10.70B
Profit Margin-48.10%
Operating Margin-58.80%
Return on Equity-182.47%
Return on Assets-31.24%
Shares Outstanding11.13M
Shares Float7.69M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%